Palasis Maria 4
4 · Lyra Therapeutics, Inc. · Filed Jan 10, 2025
Insider Transaction Report
Form 4
Palasis Maria
DirectorPresident & CEO
Transactions
- Award
Common Stock
2025-01-08+800,000→ 1,100,000 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three substantially equal installments occurring on July 1, 2025, January 1, 2026 and July 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.